Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-25

Clinical Trial Update: L. Acidophilus (Strain TW01) on Gut Health, Body Composition, and Inflammation [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study evaluating the probiotic Lactobacillus acidophilus TW01 for gut health, body composition, and inflammation in adults who are overweight o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus acidophilus TW01 (Lactobacillus acidophilus TW01 (strain TW01))

Snippet

Sponsor: University of Connecticut | Conditions: Overweight (BMI > 25), Obese, Otherwise Healthy Volunteers | EARLY_Phase 1 | Status: RECRUITING